Atorvastatin's Phototoxicity Probed | November 17, 2008 Issue - Vol. 86 Issue 46 | Chemical & Engineering News
Volume 86 Issue 46 | pp. 55-56 | Concentrates
Issue Date: November 17, 2008

Atorvastatin's Phototoxicity Probed

Underlying the healthy heart benefits of statins are potential light-induced degradation products that can cause problems
Department: Science & Technology

Medical researchers announced on Nov. 9 that statins, drugs known for reducing blood levels of cholesterol, could cut the risk of heart attack and stroke in half for people with low cholesterol and high levels of a particular protein (N. Engl. J. Med. 2008, 359, 2195). Although statins appear to have many benefits, some poorly understood and potentially adverse reactions that can take place in vivo. For example, some patients taking atorvastatin have reported skin sensitivity to the sun. Previous work with atorvastatin shows that exposing an aqueous solution of the drug to natural sunlight oxidizes its pyrrole ring, forming a phenanthrene derivative. Now, Miguel A. Miranda at Polytechnic University of Valencia, in Spain, and colleagues have used spectroscopy techniques to better understand this photochemical mechanism (Chem. Res. Toxicol., DOI: 10.1021/tx800294z). After confirming that exciting atorvastatin with light generates a phenanthrene-like photoproduct (shown), the scientists demonstrated that the photoproduct can lead to formation of tissue-damaging singlet oxygen. The researchers suggest that exchanging the substituents of atorvastatin's pyrrole ring would prevent formation of the photoproduct, but they did not test how the changes would affect the drug's therapeutic activity.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment